In recent years, breast cancer treatment has changed dramatically. One of the newer targeted medicines making headlines is Alpelisib. This targeted therapy has resulted in stabilizing the health condition as well as increasing overall survival rate.
Understanding the medication
This targeted therapy is an orally available medicine. Alpelicib is an active ingredient of Piqray 150mg Tablet for Breast Cancer treatment. It has shown effectiveness in certain mutated tumors especially in combination with other medications. Most beneficial for patients who have locally advanced breast cancer or secondary breast cancer, that's estrogen receptor positive (ER-positive), HER2-negative and has specific changes (PIK3CA mutation) in a gene.
How this medicine Targets Cancer?
Unlike traditional chemotherapy, Alpelisib targets a specific pathway that cancer cells use to grow. Firstly, they target and interfere with processes in the cells that help cancer grow. Cancer cells often utilize the specific pathway for growth and multiplication. This drug works by specifically inhibiting the action of specific enzyme.
It help to block this pathway, and hence reduce growth signals in cancer cells, which ultimately slow down the tumor progression.
When used alongside the hormone therapy, it also helps to manage resistance that cancer cells develop against standard hormone treatments.
What usage instructions should patients know?
For better results, It is important to take the medication as your doctor instructs.
You must take your tablets immediately after food at the same time of day.
Take the tablets whole with water without crushing, chewing, or breaking them, as this can affect how the medicine is absorbed.
If you vomit after taking a dose, do not take an additional one; wait for your next scheduled dose.
Thus, the effectiveness and safety of Piqray 150mg Dosage Schedule may be affected by other drugs that the patient may be using.
Are there any common side effects?
The possible side effects associated with this medicine, may require further monitoring of patients taking it. The common side effects include:
- High blood sugar level
- Rash
- Diarrhoea
- Nausea
- Vomiting
- Fatigue
- Mouth sores
- Decreased appetite
What are the safety advice for Alpelicib?
- Patient may be at risk of infection during this treatment. They should report to their doctor if any signs of infection occur.
- You should immediately report to your doctor if you have observed any signs and symptoms of allergic reactions such as rash and shortness of breath after taking Alpelisib.
- Regularly check your sugar levels and report to doctor if sugar levels are abnormally high.
- Consume food that may help reduce diarrhoea and get enough rest.
- Using a soft toothbrush and rinsing mouth at least 3 times a day with saline water can prevent mouth sores.
Conclusion
The targeted medicine, Alpelisib, is a step forward in personalized oncology. It provides a tailored therapeutic approach and doubles the duration of survival for patients with HR+, HER2 negative metastatic breast cancer. This represents the foundation of targeted breast cancer care in today's current environment.
FAQs
Q. Can diabetes patients take Alpelicib?
Yes, patients who can control type 2 diabetes can take Alpelisib. But it is not recommended for those with severe or uncontrolled diabetes.
Q. Who can receive treatment with Alpelisib?
It is used to treat hormone receptor positive & HER2-negative advanced breast cancer in women and men whose cancer has progressed after treatment.
